Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer.

Abdollah F, Arora S, von Landenberg N, Gild P, Sood A, Dalela D, Trinh QD, Menon M, Rogers C. Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer. BJU Int. 2018 03; 121(3):345-347.

View in: PubMed

subject areas

Carcinoma, Renal Cell
Humans
Kidney Neoplasms
Middle Aged
Nephrectomy
North America
Patient Selection
Randomized Controlled Trials as Topic
Survival Rate

authors with profiles

Akshay Sood

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support